PARP & DDR Inhibitors Summit 2020

PARP & DDR Inhibitors Summit is organized by Hanson Wade and will be held from Jan 28 - 30, 2020 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Description:
PARP and novel DNA Damage Response (DDR) inhibitors are showing great potential in broader tumor indications as they advance through the clinic. This industry-focused summit will equip you with the tools to optimize PARP inhibitors for expanded indications; create best-in-class therapeutics; over-ride resistance and identify novel DDR and synthetic lethal pathways to exploit cancer survival mechanisms.

• Leverage drug and therapeutic combinations with lessons learnt from PARP in the clinic
• Devise personalized treatment plans by examining genotypes and discuss biomarker strategy
• Equip your DDR inhibitors for use in expanded indications
• Inform therapeutic combination selection to overcome acquired resistance
• Analyze the emerging DDR therapeutic landscape and unpick the complex DDR network

The PARP & DDR Inhibitors Summit 2020 gathers the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development. This meeting is the perfect opportunity to gain cutting-edge insights from industry leaders on PARP inhibitor development, creating best-in-class therapeutics, over-riding resistance and identifying novel synthetic lethal pathways to exploit cancer survival mechanisms.

Step out of the office and into a meeting tailored to your niche. Round table talks, panel discussion and networking provide a unique opportunity for open conversation with industry leaders to accelerate your DDR success.

Additional details will be posted as soon as information is available.

View All10 Speaking

Neil Bhola

Clinical Pharmacology

Eleni Lagkadinou

Oncology

Sophia Gayle

Cell and Developmental Biology

Asli Muvaffak

Biotechnology